WASHINGTON (CN) - Some Hospira Carpuject pre-filled syringe cartridges contain extra medication, which may produce an overdose, according to a Food and Drug Administration press release. Pharmacies ...
The FDA is alerting healthcare providers of a potential safety risk in some Hospira Carpuject pre-filled cartridges. The pre-filled cartridges containing morphine and hydromorphone may be overfilled ...
The survey was completed by 540 nurses, predominantly staff-level registered nurses (78%) and, to a much lesser extent, nurse managers (8%) and nurse educators (8%). Most participating nurses (87%) ...
(RTTNews) - Hospira, Inc., affiliated to dug major Pfizer Inc., is recalling select lots of Buprenorphine Hydrochloride Injection Carpuject Units and Labetalol Hydrochloride Injection Carpuject Units, ...
UNDATED - Hospira, Inc., a Pfizer company, is voluntarily recalling lots 72680LL and 76510LL of Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL, Carpuject Single-use cartridge syringe ...
An investigation into user complaints of overfilled Carpuject syringes led Hospira ($HSP) to realize manufacturing problems with overfills were far more extensive ...
Hospira announced a nationwide voluntary recall of one lot of Morphine Sulfate injection, 4mg/mL, due to a customer report of two Carpujects syringes containing more than the 1mL labeled fill volume.
Hospira ($HSP), which has been trying so hard to make improvements in its manufacturing and quality-control methods in the face of plant problems, has had to recall ...
ISMP recently conducted a survey of our nursing audience on Carpuject prefilled syringe cartridges for injectable medications. The survey revealed two troubling safety issues that may place patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results